United States Transcatheter Aortic Valve Replacement Market Share & Growth Outlook | Major Players 2025 - St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation

"Transcatheter Aortic Valve Replacement (TAVR) Market is expected to grow at a CAGR 7.11% during the forecasting period (2024-2031). T" As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/transcatheter-aortic-valve-replacement-market?sp

United States: Recent TAVR Developments

✅ In September 2025, Edwards Lifesciences launched its next-generation balloon-expandable TAVR system in California.The device features enhanced deliverability and reduced paravalvular leak risk, improving patient outcomes for severe aortic stenosis.

✅ In August 2025, Medtronic invested $50 million to expand TAVR production and R&D capabilities in Minnesota.The expansion focuses on next-gen self-expanding valves and delivery systems.Commercial rollout is expected by Q1 2026.

✅ In July 2025, Boston Scientific introduced a new TAVR valve with improved hemodynamic performance in Massachusetts.The system integrates imaging-guided placement to reduce procedural complications.It targets high-risk and intermediate-risk patient populations.

✅ In June 2025, Abbott Vascular completed clinical trials for a minimally invasive TAVR delivery system in New Jersey.The trials demonstrated shorter procedure times and improved recovery outcomes.It will be scaled for commercial use by late 2025.

Japan: Recent TAVR Developments

✅ In September 2025, Edwards Lifesciences Japan launched its latest balloon-expandable TAVR system in Tokyo.The platform enhances precision placement and reduces post-procedure complications.It aligns with Japan's growing minimally invasive cardiac intervention programs.

✅ In August 2025, Medtronic Japan invested in local production and R&D for TAVR systems in Osaka.The focus is on advanced self-expanding valves and delivery mechanisms.Commercial deployment is planned for early 2026.

✅ In July 2025, Terumo Corporation introduced a new TAVR valve and delivery system in Kyoto.The device improves procedural safety and expands access to intermediate-risk patients.It supports Japan's cardiac intervention initiatives.

✅ In June 2025, Japan Lifeline completed clinical evaluations of a novel TAVR device in Fukuoka.The trials demonstrated enhanced hemodynamics and shorter recovery times.The device will be rolled out across major Japanese cardiac centers.

Transcatheter Aortic Valve Replacement Market: Drivers

The transcatheter aortic valve replacement (TAVR) market is experiencing significant growth as healthcare providers increasingly adopt minimally invasive procedures to treat aortic stenosis, especially in patients at high or intermediate surgical risk. Rising demand is driven by the growing prevalence of cardiovascular diseases, aging populations, and the need for safer, less invasive alternatives to open-heart surgery. Additionally, increasing awareness of TAVR benefits, such as reduced recovery time, shorter hospital stays, and improved quality of life, is fueling market adoption. Expansion of hospital infrastructure, rising investment in interventional cardiology programs, and increasing access to advanced cardiac care further support market growth. The emphasis on precision medicine and patient-specific treatment strategies is also contributing to rising demand.

Technological advancements are significantly enhancing TAVR procedures. Innovations in valve design, delivery systems, and catheter technology improve procedural accuracy, safety, and long-term outcomes. Development of next-generation transcatheter valves, repositionable and retrievable devices, and low-profile delivery systems enables treatment of a broader patient population. Integration with advanced imaging, 3D reconstruction, and AI-driven planning tools allows precise valve placement and reduced procedural complications. Continuous improvements in material biocompatibility, durability, and minimally invasive techniques enhance patient recovery and procedural efficiency. With ongoing innovation and growing adoption of minimally invasive cardiac interventions, the TAVR market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/transcatheter-aortic-valve-replacement-market?sp

Transcatheter Aortic Valve Replacement Market: Major Players

St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc., Direct Flow medical, Inc., Meril Life Sciences Pvt. Ltd., Transcatheter Technologies GmbH, SYMETIS SA.

Segment Covered in the Transcatheter Aortic Valve Replacement Market:

➥ By Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement, Transcatheter Pulmonary Valve Replacement, Others

➥ By Surgical Procedure: Transfemoral (TF) Implantation, Transapical (TA) Implantation, Transaortic Implantation

➥ By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Others

Research Process:

Both primary and secondary data sources have been used in the Transcatheter Aortic Valve Replacement Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Transcatheter Aortic Valve Replacement Market Research Industry:

➠ Who leads the Transcatheter Aortic Valve Replacement industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Transcatheter Aortic Valve Replacement market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Transcatheter Aortic Valve Replacement market growth?
➠ What are the dominant sales and distribution strategies in the Transcatheter Aortic Valve Replacement industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=transcatheter-aortic-valve-replacement-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.